Microglial histamine H4R in the pathophysiology of Parkinson's disease-a new actor on the stage?

Naunyn Schmiedebergs Arch Pharmacol. 2019 Jun;392(6):641-645. doi: 10.1007/s00210-019-01635-0. Epub 2019 Apr 24.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Indoles / therapeutic use
  • Lesch-Nyhan Syndrome / etiology
  • Macrophages / physiology
  • Microglia / physiology*
  • Parkinson Disease / etiology*
  • Piperazines / therapeutic use
  • Receptors, Histamine H4 / physiology*

Substances

  • Indoles
  • Piperazines
  • Receptors, Histamine H4
  • 1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine